Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs

The Journal of Clinical Investigation
Werner SeegerS Bhakdi

Abstract

Escherichia coli hemolysin has been implicated as a pathogenicity factor in extraintestinal E. coli infections including sepsis. In the present study the effects of intravascular administration of hemolysin were investigated in isolated blood-free perfused rabbit lungs. Low concentrations of the toxin in the perfusate (0.05-5 hemolytic units/ml, corresponding to approximately 5-500 ng/ml), caused a dose- and time-dependent release of potassium, thromboxane A2, and prostaglandin I2, but not of lactate dehydrogenase, into the recirculating medium, as well as a dose-dependent liberation of the prostanoids into the bronchoalveolar space. These events were paralleled by a dose-dependent pulmonary hypertension, and studies with different inhibitors collectively indicated that the vasoconstrictor response was mediated predominantly by pulmonary thromboxane generation. In addition, E. coli hemolysin elicited a protracted, dose-dependent increase in the lung capillary filtration coefficient, which was independent of the prostanoid-mediated pressor response and resulted in severe pulmonary edema formation. We conclude that E. coli hemolysin can elicit thromboxane-mediated pulmonary hypertension combined with severe vascular leakage in is...Continue Reading

References

Nov 27, 1987·Biochimica Et Biophysica Acta·G MenestrinaS Bhakdi
Oct 1, 1987·The American Review of Respiratory Disease·W SeegerH Neuhof
Mar 1, 1987·The Journal of Clinical Investigation·F B TaylorK E Blick
Aug 1, 1987·The American Review of Respiratory Disease·W Seeger, N Suttorp
Aug 28, 1986·The New England Journal of Medicine·J E Rinaldo, R M Rogers
Jan 1, 1985·Molecular & General Genetics : MGG·M I Gonzalez-CarreróJ M Ortiz
Sep 1, 1985·Archives of Internal Medicine·G P BodeyL Elting
Oct 1, 1981·The Journal of Cell Biology·R FüssleH J Wellensiek
Jan 1, 1984·Molecular & General Genetics : MGG·N Mackman, I B Holland
Jun 1, 1984·Circulation Research·K L Brigham, B Meyrick
Jun 1, 1981·British Journal of Pharmacology·N Feuerstein, P W Ramwell
Feb 1, 1982·Journal of Medical Microbiology·S J Cavalieri, I S Snyder

❮ Previous
Next ❯

Citations

Sep 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·N SugimotoM Matsuda
Jul 1, 1997·Toxicon : Official Journal of the International Society on Toxinology·N SugimotoM Matsuda
Jul 1, 1993·The Journal of Experimental Medicine·N SuttorpS Bhadki
Oct 6, 1997·American Journal of Respiratory and Critical Care Medicine·H SchütteF Grimminger
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·H SchütteF Grimminger
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·K MayerA F Grimminger
Nov 1, 1993·The American Review of Respiratory Disease·D WalmrathW Seeger
May 2, 1998·American Journal of Respiratory Cell and Molecular Biology·L ErmertW Seeger
Feb 1, 1992·American Journal of Respiratory Cell and Molecular Biology·T WuJ H Shelhamer
Dec 21, 2012·Future Microbiology·Travis J Wiles, Matthew A Mulvey
Jul 14, 2005·Scandinavian Journal of Infectious Diseases·Christina Welinder-Olsson, Bertil Kaijser
Jun 10, 2010·FEMS Microbiology Reviews·Irena LinhartováPeter Sebo
Jul 17, 2007·International Journal of Antimicrobial Agents·M S Morgan
May 24, 2013·Microbiology and Molecular Biology Reviews : MMBR·Ferdinand C O LosAdam J Ratner
Jun 28, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Weidong WuJames M Samet
Jan 6, 2006·The Journal of Pharmacology and Experimental Therapeutics·Rui ZhangKathleen M MacLeod
Oct 7, 2009·Antimicrobial Agents and Chemotherapy·Brook E RagleJuliane Bubeck Wardenburg
Mar 7, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Vasanthi R SunilDebra L Laskin
Jul 1, 1997·Journal of Applied Physiology·W SteudelW Seeger
Apr 6, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·L ErmertW Seeger
Jan 11, 2005·Critical Care Medicine·Thomas R Martin
May 1, 1993·Infection and Immunity·D JonasS Bhakdi
Nov 1, 1990·Infection and Immunity·N SuttorpS Bhakdi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.